GenSight Biologics S.A. (EPA: SIGHT)
France
· Delayed Price · Currency is EUR
0.275
-0.008 (-2.83%)
Jan 20, 2025, 5:35 PM CET
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2023. The number of employees decreased by 29 or -64.44% compared to the previous year.
Employees
16
Change (1Y)
-29
Growth (1Y)
-64.44%
Revenue / Employee
€179,636
Profits / Employee
€1,827,818
Market Cap
34.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 86,088 |
EssilorLuxottica Société anonyme | 151,292 |
Sartorius Stedim Biotech | 10,662 |
bioMérieux | 13,982 |
Ipsen | 5,325 |
Eurofins Scientific SE | 61,798 |
Virbac | 5,459 |
Ramsay Générale de Santé | 34,218 |
GenSight Biologics News
- 4 weeks ago - GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation - Business Wire
- 2 months ago - GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France - Business Wire
- 3 months ago - GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ® - Business Wire
- 3 months ago - GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update - Business Wire
- 3 months ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Business Wire
- 4 months ago - GenSight Biologics S.A. reports 1H results - Seeking Alpha
- 4 months ago - GenSight Biologics Reports Interim Financial Results for the First Half of 2024, Provides Business Updates - Business Wire
- 6 months ago - GenSight Biologics Reports Cash Position as of June 30, 2024, and Provides Business Update - Business Wire